Look for:

Our offer for

GILEAD SCIENCES INC.


ISIN:
US3755581036
WKN:
375558103

2021/11/26 19:00:01
Price
70.27 USD
Difference 0.29% (0.20)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)78,061 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)70.27 USD (400)
Ask (Ask size)70.45 USD (200)
Open69.70 USD
High70.74 USD
Low69.70 USD
Close (prev. day)70.07 USD
VWAP70.45 USD
Volume (pcs)5,659,473
Trading volume398,093,005.82
Number of trades55,670
Last size740,121

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: GILEAD SCIENCES INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/11/26 19:00:01
Price
70.27 USD
Difference 0.29% (0.20)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)78,061 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)70.27 USD (400)
Ask (Ask size)70.45 USD (200)
Open69.70 USD
High70.74 USD
Low69.70 USD
Close (prev. day)70.07 USD
VWAP70.45 USD
Volume (pcs)5,659,473
Trading volume398,093,005.82
Number of trades55,670
Last size740,121

Performance and Risk

6m1Y3Y
Perf (%)+5.91%+18.10%+4.97%
Perf (abs.)+3.92+10.77+3.33
Beta0.400.390.53
Volatility16.3519.6327.94
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)69.93 USD (7,415,739)
Ø price 30 days | Ø volume 30 days (pcs.)67.37 USD (6,680,298)
Ø price 100 days | Ø volume 100 days (pcs.)69.20 USD (6,365,563)
Ø price 250 days | Ø volume 250 days (pcs.)66.56 USD (7,351,629)
YTD High | date73.34 USD (2021/08/18)
YTD Low | date57.93 USD (2021/01/04)
52 Weeks High | date73.34 USD (2021/08/18)
52 Weeks Low | date56.56 USD (2020/12/30)

All listings for GILEAD SCIENCES INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/11/2912:1862.34 EUR0.2281
Vienna Stock Exchange2021/11/2911:3262.34 EUR0.036
Tradegate2021/11/2912:4362.28 EUR0.6578
Stuttgart2021/11/2912:4462.30 EUR0.0121
SIX Swiss Exchange2020/04/1717:3585.00 USD0.001
SIX Swiss Exchange2020/05/1117:3572.00 CHF0.001
Nasdaq2021/11/2619:0070.27 USD398.0955,670
Munich2021/11/2912:0662.20 EUR0.002
London Stock Exchange European Trade Reporting2021/11/2909:0470.09 USD0.001
Hanover2021/11/2908:5161.82 EUR0.001
Hamburg2021/11/2908:2961.82 EUR0.001
Frankfurt2021/11/2911:4762.16 EUR0.108
Duesseldorf2021/11/2912:0062.19 EUR0.006
Borsa Italiana MTF Trading After Hours2021/11/2318:0162.37 EUR0.001
Borsa Italiana MTF Global Equity Market2021/11/2617:3562.56 EUR0.038
Berlin2021/11/2908:2461.89 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1964&ID_TYPE_IMAGE_LOGO=2

Contact Details

GILEAD SCIENCES, INC.
- -
333 Lakeside Drive - 94404 Foster City
Telefon: 1-650-574-3000
Fax: 1-650-578-9264
E-mail: -

PDF Downloads

Company report: GILEAD SCIENCES INC.PDF Download

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Members of Management Board

Jacqueline BartonMember of Board of Directors
Jeffrey BluestoneMember of Board of Directors
Sandra HorningMember of Board of Directors
Anthony WeltersMember of Board of Directors
Harish M. ManwaniMember of Board of Directors
Javier RodriguezMember of Board of Directors
Kelly KramerMember of Board of Directors
Kevin LoftonMember of Board of Directors
Daniel OšDayChairman of Managing Board
Merdad ParseyMember of Executive Committee
Taiyin YangMember of Executive Committee
Andrew DickinsonMember of Executive Committee
Brett PletcherMember of Executive Committee
Christi L. ShawMember of Executive Committee
Flavius MartinMember of Executive Committee
Johanna MercierMember of Executive Committee
Jyoti MehraMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer